As a cell surface heparan sulfate proteoglycan, GPC1 was found to exhibit a mitogenic response to multiple heparin-binding growth factors and lead to progression in breast cancer (Matsuda et al., 2001). This evidence concerns the gene CD44 and breast cancer.